These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 39298596)
1. Psychedelic research at a crossroads. Armstrong SB; Davis AK Science; 2024 Sep; 385(6715):1255. PubMed ID: 39298596 [TBL] [Abstract][Full Text] [Related]
3. Compassionate use of psychedelics. Greif A; Šurkala M Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195 [TBL] [Abstract][Full Text] [Related]
4. The Emerging Field of Psychedelic Psychotherapy. Barber GS; Aaronson ST Curr Psychiatry Rep; 2022 Oct; 24(10):583-590. PubMed ID: 36129571 [TBL] [Abstract][Full Text] [Related]
5. Psychedelic drugs-a new era in psychiatry? . Nutt D Dialogues Clin Neurosci; 2019; 21(2):139-147. PubMed ID: 31636488 [TBL] [Abstract][Full Text] [Related]
6. The emerging role of psilocybin and MDMA in the treatment of mental illness. Gill H; Gill B; Chen-Li D; El-Halabi S; Rodrigues NB; Cha DS; Lipsitz O; Lee Y; Rosenblat JD; Majeed A; Mansur RB; Nasri F; Ho R; McIntyre RS Expert Rev Neurother; 2020 Dec; 20(12):1263-1273. PubMed ID: 32954860 [TBL] [Abstract][Full Text] [Related]
7. Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations. Wolfgang AS; Hoge CW Curr Psychiatry Rep; 2023 Oct; 25(10):513-532. PubMed ID: 37682446 [TBL] [Abstract][Full Text] [Related]
8. What is needed for the roll-out of psychedelic treatments? Xenakis SN; Shannon SM Curr Opin Psychiatry; 2024 Jul; 37(4):277-281. PubMed ID: 38726805 [TBL] [Abstract][Full Text] [Related]
9. Review of potential psychedelic treatments for PTSD. Henner RL; Keshavan MS; Hill KP J Neurol Sci; 2022 Aug; 439():120302. PubMed ID: 35700643 [TBL] [Abstract][Full Text] [Related]
10. United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020. Barnett BS; Parker SE; Weleff J Int J Drug Policy; 2022 Jan; 99():103473. PubMed ID: 34624734 [TBL] [Abstract][Full Text] [Related]
11. [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges]. Majić T; Jungaberle H; Schmidt TT; Zeuch A; Hermle L; Gallinat J Fortschr Neurol Psychiatr; 2017 Jul; 85(7):383-392. PubMed ID: 28768346 [No Abstract] [Full Text] [Related]
12. Psychedelic Therapy: A Primer for Primary Care Clinicians-Historical Perspective and Overview. Tabaac BJ; Shinozuka K; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS Am J Ther; 2024 Mar-Apr 01; 31(2):e97-e103. PubMed ID: 38518266 [TBL] [Abstract][Full Text] [Related]
13. Ethical considerations for psychedelic-assisted therapy in military clinical settings. Hoener S; Wolfgang A; Nissan D; Howe E J Med Ethics; 2024 Mar; 50(4):258-262. PubMed ID: 37253556 [TBL] [Abstract][Full Text] [Related]
14. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer. Barnett BS; Greer GR J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406 [TBL] [Abstract][Full Text] [Related]
15. Psychedelic Therapy Scrutinized by FDA Advisory Committee? Marks M JAMA; 2024 Sep; 332(12):963-964. PubMed ID: 39078646 [TBL] [Abstract][Full Text] [Related]
17. Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science. Adams DR; Allen H; Nicol GE; Cabassa LJ Transl Behav Med; 2024 Oct; ():. PubMed ID: 39419768 [TBL] [Abstract][Full Text] [Related]
18. Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine. De Gregorio D; Aguilar-Valles A; Preller KH; Heifets BD; Hibicke M; Mitchell J; Gobbi G J Neurosci; 2021 Feb; 41(5):891-900. PubMed ID: 33257322 [TBL] [Abstract][Full Text] [Related]
19. US could soon approve MDMA therapy - opening an era of psychedelic medicine. Reardon S Nature; 2023 Apr; 616(7957):428-430. PubMed ID: 37076730 [No Abstract] [Full Text] [Related]